Home
About
Learn
Programs
Support
Get involved
News
Donate

Learn

Which ovarian cancers don't show up on a CA125 test — and why

Reviewed

If you have been told your CA125 blood test is “normal,” it is natural to feel reassured. But a normal CA125 does not rule ovarian cancer out. Several types of ovarian cancer often produce little or no CA125 — which means the test can miss them entirely. Understanding why can help you and your care team look beyond a single number.

What CA125 actually measures

CA125 is a protein (also called MUC16) that can be shed into the blood by some ovarian cancer cells. A blood test measures how much is present. Doctors most often use CA125 to monitor a cancer that has already been diagnosed — watching whether levels fall during treatment or rise again afterward — rather than to find cancer in the first place.

There are two reasons CA125 is an imperfect signal:

  • It can be high without cancer. Common, non-cancerous conditions raise CA125, including endometriosis, uterine fibroids, pelvic inflammatory disease, normal menstruation, pregnancy, and liver disease. A raised result often has an innocent explanation.
  • It can be normal with cancer. Many ovarian cancers make little CA125, especially in the early stages and in certain subtypes. Studies have found that roughly half of women with early-stage (stage I) ovarian cancer have a CA125 in the normal range.

For those reasons, major medical bodies do not recommend CA125 as a screening test for women at average risk. It is a useful tool in the right context, not a reliable all-clear.

Ovarian cancer is not one disease

“Ovarian cancer” is really a family of different cancers that behave differently and respond to different treatments. CA125 is most closely tied to the most common type, high-grade serous carcinoma. The subtypes below tend to produce less CA125 — or signal through entirely different markers — so a normal CA125 is least reassuring when one of these is involved.

Ovarian cancer type How it tends to behave on CA125
Low-grade serous May rise, but often less than high-grade disease; can be normal early
Mucinous Frequently normal; CEA and CA19-9 are often more informative
Clear cell Variable and often only modestly raised; not reliable
Endometrioid Variable; may be normal, especially when caught early
Brenner tumor Usually unhelpful; most are benign
Germ cell tumors Typically normal; AFP, hCG and LDH are the key markers
Sex cord-stromal Usually normal; inhibin, AMH and estradiol matter more

Explore each type in depth:

Why these cancers slip past the test

The short answer is biology. CA125 comes from cells that resemble the lining of the fallopian tube — the tissue high-grade serous cancers arise from. Other ovarian cancers grow from different cell types: mucinous cancers resemble intestinal lining, clear cell and endometrioid cancers are linked to endometriosis, germ cell tumors arise from egg-forming cells, and sex cord-stromal tumors come from the hormone- producing tissue of the ovary. Because they start from different cells, many of them simply do not make much CA125. Some announce themselves through other substances instead — a germ cell tumor may raise AFP or hCG, and a granulosa cell tumor may raise inhibin or estrogen.

What to do when CA125 is normal but something feels wrong

A normal CA125 should never override persistent symptoms. See a doctor — and consider asking to see a gynecologic oncologist — if you have ongoing:

  • Bloating or a feeling of fullness that does not go away
  • Pelvic or abdominal pain
  • Difficulty eating or feeling full quickly
  • Needing to urinate urgently or often

Ways your care team can look further than CA125 include:

  • Imaging — a transvaginal ultrasound, and sometimes CT or MRI, to look directly at the ovaries.
  • Other tumor markers — depending on your age and the type of mass suspected, tests such as CEA, CA19-9, AFP, hCG, LDH, or inhibin can be far more informative than CA125.
  • Specialist referral and, ultimately, tissue — many ovarian cancers can only be confirmed by examining tissue removed during surgery. A gynecologic oncologist can advise on the right next step.

If your symptoms persist and you do not feel heard, it is reasonable to seek a second opinion. You know your body.

Why this matters to us

At the Cure Ovarian Cancer Foundation, the cancers CA125 can miss are close to our heart — they are exactly where earlier, better detection would change the most lives. Your support helps fund research into more reliable tests and treatments for these under-recognized subtypes, and helps families facing ovarian cancer today.

This page is for education and awareness and is not a substitute for medical advice. Please talk with your own care team about your symptoms, tests, and options.

Sources